OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
300596$44.8259

Rianlon Corp

Commodity ChemicalsVerified

Rianlon Corp has a market capitalization of 10.29 billion CNY and a price-to-earnings ratio of 20.73, which is above the industry median for commodity chemicals. The company's price-to-book ratio of 2.13 suggests that the market is valuing its equity at a premium relative to its book value. The enterprise value to EBITDA ratio of 25.59 indicates a relatively high valuation compared to its earnings before interest, taxes, depreciation, and amortization. The company's return on equity of 10.29% is strong, outperforming the industry median for commodity chemicals. However, its return on assets of 4.72% is in line with the industry average, indicating that the company is not generating significantly higher returns from its asset base compared to its peers. The debt-to-equity ratio of 0.85 suggests a moderate level of leverage, with total liabilities of 5.69 billion CNY and total equity of 4.83 billion CNY. Rianlon Corp's revenue of 6.02 billion CNY is concentrated in the commodity chemicals segment, with no disclosed geographic breakdown. The company's operating cash flow of 378.21 million CNY and free cash flow of 470.71 million CNY indicate a strong ability to generate cash from operations. However, the capital expenditure of -242.36 million CNY suggests that the company is not investing heavily in new projects or capacity expansion. The company's growth trajectory is expected to remain stable, with no significant changes in revenue or earnings projected for the next fiscal year. The current fiscal year is expected to show a modest increase in revenue and earnings, but the next fiscal year is not expected to see a substantial acceleration in growth. The company's liquidity position is rated as medium, with a current ratio of 1.3, indicating that it has sufficient current assets to cover its current liabilities. Rianlon Corp faces a moderate level of risk, with a liquidity risk that is rated as medium. The company's key financial flags include a negative net cash position after subtracting total debt, which could impact its ability to meet short-term obligations. The dilution risk is rated as low, with no significant dilution expected in the near term. The company's capital structure is relatively stable, with a debt-to-equity ratio of 0.85 and a total debt of 4.11 billion CNY. Recent events and filings indicate that Rianlon Corp has not issued any new shares or raised additional capital in the recent past. The company's recent earnings call transcripts and investor relations communications have not highlighted any major strategic shifts or new initiatives. The company's focus remains on maintaining its current operations and optimizing its existing asset base to generate consistent cash flows.

30-day price · 300596(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyRianlon Corp
Ticker300596.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Rianlon Corp is a Chinese chemical company that produces commodity chemicals and generates revenue primarily through the sale of chemical products.

Classification. Rianlon Corp is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with a confidence level of 0.92.

Rianlon Corp has a market capitalization of 10.29 billion CNY and a price-to-earnings ratio of 20.73, which is above the industry median for commodity chemicals. The company's price-to-book ratio of 2.13 suggests that the market is valuing its equity at a premium relative to its book value. The enterprise value to EBITDA ratio of 25.59 indicates a relatively high valuation compared to its earnings before interest, taxes, depreciation, and amortization. The company's return on equity of 10.29% is strong, outperforming the industry median for commodity chemicals. However, its return on assets of 4.72% is in line with the industry average, indicating that the company is not generating significantly higher returns from its asset base compared to its peers. The debt-to-equity ratio of 0.85 suggests a moderate level of leverage, with total liabilities of 5.69 billion CNY and total equity of 4.83 billion CNY. Rianlon Corp's revenue of 6.02 billion CNY is concentrated in the commodity chemicals segment, with no disclosed geographic breakdown. The company's operating cash flow of 378.21 million CNY and free cash flow of 470.71 million CNY indicate a strong ability to generate cash from operations. However, the capital expenditure of -242.36 million CNY suggests that the company is not investing heavily in new projects or capacity expansion. The company's growth trajectory is expected to remain stable, with no significant changes in revenue or earnings projected for the next fiscal year. The current fiscal year is expected to show a modest increase in revenue and earnings, but the next fiscal year is not expected to see a substantial acceleration in growth. The company's liquidity position is rated as medium, with a current ratio of 1.3, indicating that it has sufficient current assets to cover its current liabilities. Rianlon Corp faces a moderate level of risk, with a liquidity risk that is rated as medium. The company's key financial flags include a negative net cash position after subtracting total debt, which could impact its ability to meet short-term obligations. The dilution risk is rated as low, with no significant dilution expected in the near term. The company's capital structure is relatively stable, with a debt-to-equity ratio of 0.85 and a total debt of 4.11 billion CNY. Recent events and filings indicate that Rianlon Corp has not issued any new shares or raised additional capital in the recent past. The company's recent earnings call transcripts and investor relations communications have not highlighted any major strategic shifts or new initiatives. The company's focus remains on maintaining its current operations and optimizing its existing asset base to generate consistent cash flows.
Key takeaways
  • Rianlon Corp has a strong return on equity of 10.29%, outperforming the industry median.
  • The company's price-to-earnings ratio of 20.73 is above the industry median, indicating a premium valuation.
  • Rianlon Corp's liquidity position is rated as medium, with a current ratio of 1.3.
  • The company's debt-to-equity ratio of 0.85 suggests a moderate level of leverage.
  • Rianlon Corp's free cash flow of 470.71 million CNY indicates a strong ability to generate cash from operations.
  • The company's growth trajectory is expected to remain stable, with no significant changes in revenue or earnings projected for the next fiscal year.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$6.02B
Gross profit$1.27B
Operating income$562.5M
Net income$496.6M
R&D
SG&A
D&A
SBC
Operating cash flow$378.2M
CapEx-$242.4M
Free cash flow$470.7M
Total assets$10.52B
Total liabilities$5.69B
Total equity$4.83B
Cash & equivalents
Long-term debt$4.11B
Valuation
Market price$44.82
Market cap$10.29B
Enterprise value$14.40B
P/E20.7
Reported non-GAAP P/E
EV/Revenue2.4
EV/Op income25.6
EV/OCF38.1
P/B2.1
P/Tangible book2.1
Tangible book$4.83B
Net cash-$4.11B
Current ratio1.3
Debt/Equity0.8
ROA4.7%
ROE10.3%
Cash conversion76.0%
CapEx/Revenue-4.0%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric300596Activity
Op margin9.3%0.4% medp25 -8.0% · p75 16.0%above median
Net margin8.2%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin21.2%20.8% medp25 14.9% · p75 24.0%above median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-4.0%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity85.0%59.0% medp25 54.9% · p75 72.9%top quartile
Observations
IR observations
Mean price target46.75 CNY
Median price target47.33 CNY
High price target58.00 CNY
Low price target34.35 CNY
Mean recommendation1.60 (1=strong buy, 5=strong sell)
Strong-buy count2.00
Buy count3.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate2.79 CNY
Last actual EPS2.16 CNY
Source: analysis-pipeline (hybrid)Generated: 2026-05-21 03:57 UTCJob: 3e1d3be1